Charles Schwab Investment Management »

Diamedica Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Diamedica Therapeutics (DMAC) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Diamedica Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Diamedica Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Diamedica Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $38k 13k 2.84
2023-09-30 $34k 13k 2.58
2023-06-30 $57k 13k 4.32